COVID-19 Neurologic Complications: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 14: | Line 14: | ||
*'''Pathophysiology''' | *'''Pathophysiology''' | ||
**The exact pathogenesis of headache in COVID 19 patients is not fully understood. | **The exact [[pathogenesis]] of [[headache]] in COVID 19 [[Patient|patients]] is not fully understood. | ||
**It is thought that headache is the result of: | **It is thought that [[headache]] is the result of: | ||
***Cytokine release | ***[[Cytokine]] release: | ||
***Direct invasion | ***Direct [[invasion]] | ||
***Metabolic disturbances | ***[[Metabolic]] disturbances | ||
***Inflammation | ***[[Inflammation]] | ||
***Dehydration | ***[[Dehydration]] | ||
***Hypoxia | ***[[Hypoxia]] | ||
[[File:Photo 2020-06-24 15-35-07.jpg|500px|none|thumb|By {{Fs}} / https://en.wikipedia.org/wiki/File:Migraine.jpg]] | [[File:Photo 2020-06-24 15-35-07.jpg|500px|none|thumb|By {{Fs}} / https://en.wikipedia.org/wiki/File:Migraine.jpg]] | ||
| Line 138: | Line 138: | ||
<br /> | <br /> | ||
==References== | ==References== | ||
<references /> | |||
Revision as of 20:42, 24 June 2020
To go to the COVID-19 project topics list, click here.
|
COVID-19 Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
COVID-19 Neurologic Complications On the Web |
|
American Roentgen Ray Society Images of COVID-19 Neurologic Complications |
|
Risk calculators and risk factors for COVID-19 Neurologic Complications |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D., Rinky Agnes Botleroo, M.B.B.S.
Overview
Pathophysiology of the Complications in the Nervous System
Mechanism of targetting the Nervous System
Complications in the Central Nervous System
Headache
- Pathophysiology
- The exact pathogenesis of headache in COVID 19 patients is not fully understood.
- It is thought that headache is the result of:
- Cytokine release:
- Direct invasion
- Metabolic disturbances
- Inflammation
- Dehydration
- Hypoxia
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Cerebrovascular Accident/Stroke
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Acute Encephalitis
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Viral Meningitis
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Epileptic Seizures
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Encephalopathy
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Complications in the Peripheral Nervous system
Guillain-Barre syndrome
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Anosmia
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Acute Myelitis
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Miller Fischer Sydrome
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Polyneuritis Cranialis
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Complications due to medication interaction
1. Statin induced myotoxicity
- Myalgia, myopathies, rhabdomyolysis
2. 2nd and 3rd degree atrioventricular block
- Lopinavir/ Ritonavir (Kaltera) (400 mg/100 mg)
3. Prolong QTc interval
- Chloroquine/Hydroxychloroquine
4. Myelotoxicity
- Ribavirin
5. Prolonged PR interval
- Atazanavir
6. Myelosuppression
7.